| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
-2.49 |
0.58 |
-14.29 |
-15.28 |
-2.35 |
|
| Diluted EPS (Rs.) |
-2.49 |
0.58 |
-14.29 |
-15.28 |
-2.35 |
|
| Cash EPS (Rs.) |
0.83 |
4.02 |
-10.29 |
-10.96 |
1.98 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
51.22 |
50.20 |
49.63 |
64.24 |
79.43 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
51.22 |
50.20 |
49.63 |
64.24 |
79.43 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
50.55 |
58.71 |
41.97 |
38.45 |
56.09 |
|
| PBDIT/Share (Rs.) |
1.58 |
6.38 |
-4.60 |
-9.81 |
3.47 |
|
| PBIT/Share (Rs.) |
-1.73 |
2.94 |
-8.60 |
-14.13 |
-0.87 |
|
| PBT/Share (Rs.) |
-4.25 |
0.69 |
-10.25 |
-15.28 |
-2.10 |
|
| Net Profit/Share (Rs.) |
-2.48 |
0.58 |
-14.29 |
-15.28 |
-2.36 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
3.12 |
10.86 |
-10.96 |
-25.52 |
6.18 |
|
| PBIT Margin (%) |
-3.42 |
5.00 |
-20.49 |
-36.74 |
-1.55 |
|
| PBT Margin (%) |
-8.41 |
1.16 |
-24.41 |
-39.73 |
-3.74 |
|
| Net Profit Margin (%) |
-4.91 |
0.98 |
-34.05 |
-39.73 |
-4.20 |
|
| Return on Networth / Equity (%) |
-4.85 |
1.15 |
-28.79 |
-23.78 |
-2.96 |
|
| Return on Capital Employed (%) |
-2.04 |
3.56 |
-11.18 |
-16.79 |
-0.90 |
|
| Return on Assets (%) |
-1.75 |
0.47 |
-12.09 |
-12.28 |
-1.82 |
|
| Total Debt/Equity (X) |
0.73 |
0.39 |
0.32 |
0.20 |
0.12 |
|
| Asset Turnover Ratio (%) |
0.38 |
0.49 |
0.35 |
0.30 |
43.40 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.84 |
0.74 |
0.81 |
1.17 |
1.46 |
|
| Quick Ratio (X) |
0.40 |
0.30 |
0.35 |
0.65 |
1.02 |
|
| Inventory Turnover Ratio (X) |
0.95 |
1.11 |
1.07 |
1.59 |
3.95 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
2,867.47 |
838.39 |
722.84 |
949.50 |
1,059.69 |
|
| EV/Net Operating Revenue (X) |
9.25 |
2.33 |
2.81 |
4.03 |
3.08 |
|
| EV/EBITDA (X) |
295.92 |
21.46 |
-25.64 |
-15.80 |
49.90 |
|
| MarketCap/Net Operating Revenue (X) |
8.72 |
2.07 |
2.58 |
3.86 |
3.16 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
8.60 |
2.42 |
2.18 |
2.31 |
2.23 |
|
| Price/Net Operating Revenue |
8.72 |
2.07 |
2.58 |
3.86 |
3.16 |
|
| Earnings Yield |
-0.01 |
0.00 |
-0.13 |
-0.10 |
-0.01 |
|
Source : Dion Global Solutions Limited
